Home>Topics>>Lexicon Pharmaceuticals ([[LXRX]] +15.4%) moves up today on no company-specific news. The company earned fast track status earlier this month from the FDA for its LX1033 drug candidate, an orally ...
Lexicon Pharmaceuticals ([[LXRX]] +15.4%) moves up today on no company-specific news. The company earned fast track status earlier this month from the FDA for its LX1033 drug candidate, an orally ...
Lexicon Pharmaceuticals (
LXRX +15.4% ) moves up today on no company-specific news. The company earned fast track status earlier this month from the FDA for its LX1033 drug candidate, an orally delivered small molecule medication for irritable bowel syndrome with diarrhea. Post your comment!
Read the rest of this article on SeekingAlpha.com: SA Currents